Impact of Nirsevimab Prophylaxis on RSV Dynamics: A Stage-Structured Modelling Study

AI justification

Scientific evidence supports public health intervention reducing infant disease burden. | The study provides evidence-based support for a public health intervention (Nirsevimab prophylaxis) that reduces respiratory syncytial virus (RSV) burden, particularly in vulnerable infant populations. While the intervention does not fully eliminate epidemic transmission, it significantly lowers incidence and offers indirect protection to older age groups, aligning with SDG 3 (Good Health and Well-being).